Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Is Axsome Therapeutics a Buy on the Dip?

Key PointsAxsome Therapeutics has launched exciting new drugs over the past year, and they are delivering growth.

We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at nasdaq.com →

More in Finance & Markets

KOSPI Up 2.66% Friday

[Economy] : The benchmark Korea Composite Stock Price Index surged 178-point-82 points, or two-point-66 percent, on Friday to close at six-thousand-894-point-23.

More from Friday 18 September →